More than 6 million Americans have Alzheimer’s disease, and the CDC expects that number to double in the next three decades.
The first drug fully approved by the FDA for Alzheimer’s has been on the market for 10 months. Now, researchers are looking at testing it to prevent Alzheimer’s.
A shot that could one day prevent Alzheimer’s disease — that’s the potential future for lecanemab, or Leqembi.[…]
Researchers are studying to see if the drug can prevent the disease.
“We hope [to] make breakthroughs in discoveries that change our ability to help people in their lives, prevent them from getting memory problems,” said Joshua Grill, professor of neurobiology and behavior at the University of California, Irvine.
Read the article here.